Ambu A/S

Research Ambu A/S (AMBU-B) on Bullrun: valuation model: fairly valued, market cap DKK 16.06B, P/E 34.1, dividend yield 0.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAMBU-B
• ExchangeCO
• CountryDenmark
• SectorHealthcare
• IndustryMedical Devices
• CurrencyDKK
• Valuation signalfairly valued
• Market capDKK 16.06B
• P/E34.1
• Dividend yield0.7%
• Financial periodFY2025

Valuation Snapshot

Bullrun's latest valuation model marks Ambu A/S as fairly valued; latest market cap is DKK 16.06B; P/E is 34.1; dividend yield is 0.7%.

About Ambu A/S

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products;

Frequently asked questions

Is Ambu A/S overvalued or undervalued?

Bullrun's valuation model currently marks Ambu A/S as fairly valued.

What is Ambu A/S's market cap?

Ambu A/S's market capitalization is DKK 16.06B.

What is Ambu A/S's P/E ratio?

Ambu A/S's price-to-earnings (P/E) ratio is 34.1.

Does Ambu A/S pay a dividend?

Ambu A/S has a dividend yield of 0.7%.

What does Ambu A/S do?

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally.